Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Boston Scientific TAVR ACURATE Prime Aortic Valve System

Boston Scientific’s new TAVR valve gains CE mark approval

The self-expanding Acurate Prime Aortic Valve System was designed with improved valve positioning in mind. According to Boston Scientific, it it will be available in more sizes than the company's previous TAVR device to ensure it can treat as many heart patients as possible. 

Cardiac CT outperforms stress tests when screening liver transplant candidates for CAD

Heart issues are the No. 1 cause of death for liver transplant patients. Screening patients for signs of CAD is one way care teams can help keep such complications to a minimum. 

TCT 2023 crowd

CRF announces late-breaking clinical trials for TCT 2024

The Cardiovascular Research Foundation has announced 10 late-breaking clinical trials and 15 late-breaking clinical science sessions for TCT 2024 in Washington, DC. Topics will include TAVR and other structural heart procedures, artificial intelligence and much more. 

New PET technique improves imaging of pediatric neuroblastoma.

New PET technique slashes scan times, improves image quality in neuroblastoma cases

The method also reduces radiation doses and eliminates the need for sedation or general anesthesia.

doctor examines patient data on their tablet

PaceMate acquires Medtronic workflow tech, promising ‘unparalleled support’ for heart patients

The Florida-based healthcare company, already a leading name in cardiac data management, said the acquisition will help its technology reach more heart teams than ever before.

Thumbnail

Odds of late-stage cancer diagnosis double when women put off annual breast cancer screening

Biennial and intermittent screening also significantly decrease rates of overall survival, a new analysis shows.

Medicare coverage for weight loss drug semaglutide could cost up to $145B per year

Medications that target obesity are not typically covered by Medicare. When the FDA approved semaglutide as a way to treat certain cardiovascular risks, however, CMS said Medicare coverage was on the table. 

Pedro Martinez Clark, MD, is helping to addressing health disparities and high PAD and CLI rates in Latin and Haitian communities in Miami.

Addressing high PAD and CLI rates in Latin and Haitian communities of Miami

Pedro Martinez Clark, MD, FSCAI, interventional cardiologist, medical director of Amavita Heart and Vascular Health in Miami, set up community outreach efforts to screen patients in low-income neighborhoods.